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Case Number 9
Superior Mesenteric Venous Thrombosis
Ramona Camilleri 
Reviewed by: Mr. Ernest Ellul 
Case summary:
Demographic details:
Mr. G.B., male, Birkirkara.
Referred from: GP.
Mr. G.B., a 69-year-old gentleman, was admitted with severe periumbilical pain radiating to the left 
lower quadrant. A diagnostic CT scan revealed superior mesenteric vein thrombosis as the underlying 
cause for the pain. In view of the fact that there were no contraindications to thrombolysis, it was possible 
to manage this patient with medical treatment using recombinant tissue plasminogen activator (rt-PA; 
Alteplase). The patient’s condition improved and he was deemed fit for discharge on long-term warfarin 
ten days after admission. 
The aetiology of thrombus formation in this gentleman is not as yet known. Further investigations will 
need to be carried out in order to find the underlying cause.
Presenting complaint:
Gentleman presented with a three week history of episodic worsening lower abdominal pain, associated 
with nausea and one episode of vomiting.
History of presenting complaint:
The pain was severe in nature, worse in the periumbilical area and in the left lower quadrant. It was 
associated with nausea and one episode of vomiting. It was not relieved by rest, paracetamol or by 
opening bowels. 
The patient complained of reduced appetite and reduced frequency of bowel opening. Patient last opened 
his bowels on the morning of admission. He denies any blood with stools, malaena, haematemesis or 
coffee-ground vomitus. 
There was no associated weight loss, fever, chills, rigors or lower urinary tract symptoms. 
Past medical and surgical history: 
Past medical history:
Chronic obstructive pulmonary disease
Hypertension
Hypercholesterolemia 
Depression
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Past surgical history:
Stabilization of T12 and L1 fracture (2009) 
Movement under anaesthesia and external fixation of fractured tibia and fibula (2009)
Drug history:
Drug Dosage Frequency Type Reason
Ipratropium 2 puffs BD Anticholinergic Shortness of breath 
Budesonide 2 puffs BD Inhaled corticosteroid Shortness of breath 
Quetiapine 50mg Nocte Atypical antipsychotic Depression
Lorazepam 2mg Nocte Short-acting benzodiazepine Depression
Paroxetine 20mg Daily SSRI antidepressant Depression
Simvastatin 40mg Nocte Statin Hypercholesterolaemia
The patient suffers from no known drug allergies.
Family history:
Father died of a myocardial infarction at 50 years of age.
Mother had hypercholesterolaemia.
Social history: 
Mr. G.B. smokes four cigars daily and does not drink alcohol. He lives with his wife and has good social 
support. He is fully mobile and copes well with activities of daily living. He is currently a pensioner and 
used to work as a teacher. 
Systemic inquiry:
Systemic enquiry revealed episodic headaches but was otherwise unremarkable.
Discussion of results of general and specific examinations:
General examination:
Patient was alert, not distressed and afebrile. Glasgow Coma scale 15/15. 
Respiratory examination: 
Respiratory rate: 26 breaths/min
Oxygen saturations: 100% on air. 
Chest was clear and there was good air entry bilaterally
Cardiovascular examination:
Capillary refill time: <2seconds
Pulse: 100bpm
Blood pressure: 185/95mmHg
Heart sounds: HS1+ S2+0 
Abdominal examination: 
Soft abdomen, no distension, tender in epigastrium and left lower quadrant. No rebound tenderness and 
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no guarding.  Percussion tenderness present on left side of the abdomen. No masses were palpable. 
Direct rectal examination: brown stools, enlarged prostate, no blood or malaena present.
Differential diagnosis: 
• Superior mesenteric vein thrombosis 
• Superior mesenteric artery occlusion
• Abdominal malignancy 
• Diverticulitis
• Inflammatory bowel disease 
• Pancreatitis
• Submucosal haemorrhage or haematoma 
Diagnostic procedures:
Laboratory exams:
Test: Bloods: Complete blood count.
Justification for test: Infection, anaemia, thrombocytopaenia.
Result: White cell count raised, raised neutrophils.
Conclusion: Leukocytosis present. No anaemia or thrombocytopaenia.
Test: Bloods: Urea and electrolytes, creatinine.
Justification for test: Renal function, electrolyte balance.
Result: Potassium raised (5.92).
Conclusion: Hyperkalaemia present.
Test: Bloods: Amylase.
Justification for test: Query pancreatitis.
Result: Normal.
Conclusion: Pancreatitis unlikely.
Test: Bloods: Arterial blood gases.
Justification for test: Acid-base status, query sepsis.
Result: pH 7.65, pCO2 15.6, Base Excess -6.1, HCO3: 13.6, Lactate 1.9. 
Conclusion: Compensated respiratory alkalosis, no sepsis.
Test: APTT, INR.
Justification for test: Baseline, query need for thrombolysis.
Result: INR: 1.13, APTTr: 0.90.
Conclusion: No contra indication to thrombolysis.
Instrumental exams:
Test: Chest X-ray.
Justification for test: Active lung lesions, hypertension, air under diaphragm.
Result: No active lung lesion was noted. No cardiomegaly present and no perforation suspected.
Conclusion: Normal chest X-ray.
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Test: Abdominal X-ray.
Justification for test: Acute abdomen, bowel perforation, impacted faeces, bowel obstruction.
Result: No air or fluid levels were noted. Metallic fixation of the vertebral bodies was seen.
Conclusion: No signs of bowel perforation, obstruction or impacted faeces.
Test: CT scan  (Figure 1).
Justification for test: To find aetiology of pain, exclude malignancy. 
Result: Superior mesenteric vein thrombosis extending to the portal confluence with correspondent 
jejunum and proximal ileum. Mesenteric panniculitis. Small ascites. Diverticular disease of the large 
bowel. 
Conclusion: Superior mesenteric vein thrombosis diagnosed. 
Figure 1: CT scan showing thrombosis of superior mesenteric vein.
Management and therapy:
1. Patient was reviewed and admitted to intensive therapy unit (in view of his condition).
2. He was kept nil by mouth.
3. Nasogastric tube was inserted and stomach contents aspirated. 
4. Urinary catheter was inserted  with urinometer – input and output charting was monitored hourly. 
5. Fluids were administered – 1L normal saline alternating with 5% dextrose I L 6 hourly. 
6. Parameters were monitored hourly (including: pulse, blood pressure, temperature, oxygen 
saturations).
7. Medications were started as shown below.
Drugs:
Drug Dosage Frequency Type Reason
Cefuroxime 750mg IV TDS Antibiotic Empirical
Metronidazole 500mg IV TDS Antibiotic Empirical
Omeprazole 40mg IV Daily Protein pump inhibitor Reduces risk of bleeding
Paracetamol 1g IV QDS Analgesic Pain relief
Pethidine 75mg IM TDS/PRN Analgesic Pain relief
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Prochlorperazine 
(Stemetil)
12.5mg 
IM
TD/PRN Dopamine antagonist Anti-emetic
Alteplase See below See below Tissue plasminogen 
activator 
To dissolve thrombus in SMV
Thrombolysis: In view of the fact that there was probably prolonged onset and there were no 
contraindications to thrombolysis, it was decided to thrombolyse the patient using alteplase 0.9mg/kg. 
Patient weighed 82kg and therefore a total of 73mg alteplase was administered as follows:
-10mg as IV bolus
-50mg over 1 hour 
-15mg over the next hour
Following thrombolysis, an unfractionated heparin infusion 6000U IV 6-hourly was started. APTT was 
checked after 6 hours of starting heparin and an APTTr  of 2.5 - 3 was aimed for. 
Diagnosis:
Superior mesenteric vein thrombosis is a relatively uncommon condition which carries significantly high 
morbidity and mortality rates. It causes 5-15% of cases of acute mesenteric ischaemia and its prognostic 
outcome depends on early diagnosis and adequate treatment. A high level of clinical suspicion is therefore 
required to ensure prompt and effective treatment administration. 
Relevant Anatomy (Figure 2): 
The superior mesenteric vein is formed by the jejunal, ileal, ileocolic, right colic and middle colic veins. 
The inferior mesenteric vein joins the splenic vein which in turn join the superior mesenteric vein to form 
the portal vein. The superior mesenteric vein drains the small intestine, caecum, ascending colon and 
transverse colon.  
Figure 2: Anatomy of superior mesenteric vein.
Aetiology:
• Patients at increased risk of thrombus formation include those having:
• Hypercoaguable states – polycythaemia vera, protein C deficiency, protein S deficiency, anti-
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thrombin III deficiency.
• Visceral infection and inflammation – diverticulitis, pancreatitis, perforated viscus.
• Malignancy (by direct invasion and by hypercoaguable state).
• Abdominal trauma.
• Post-abdominal surgery – including, but not limited to, post-splenectomy, Roux-en-Y gastric 
bypass, colectomy. 
• Portal hypertension.
• Drugs – oral contraceptive pill.
The most common cause is intra-abdominal sepsis and up to 20% of cases are idiopathic (Medscape, 
2012). 
Pathophysiology:
The underlying pathophysiology of acute mesenteric ischaemia is due to an increased fluid volume in 
the bowel wall and lumen which results in systemic hypovolaemia and haemoconcentration. Thrombus 
formation in the superior mesenteric vein occludes the outflow of blood. This together with resulting 
bowel wall oedema, impede inflow of arterial blood leading to bowel ischaemia. 
Presentation: 
Patient typically complains of generalised severe periumbilical pain which gradually worsens over a 
few days and is associated with fever, nausea and vomiting. On examination, the abdomen is usually 
distended and tender. 
Relevant Investigations:
Haematological investigations mainly help to exclude other possible causes. They may reveal leucocytosis 
and haemoconcentration. Other useful haematological investigations which would aid in diagnosing 
the cause, include protein C and S deficiencies, anti-thrombin III antibodies, abnormalities in lupus 
anticoagulant, cardiolipin antibody, platelet aggregation studies. 
Imaging should include:
-Abdominal X-ray - may reveal dilated loops of bowel, air under diaphragm
-CT scan or angiography – diagnostic 
-ECG – especially in this case in view of hyperkalaemia
Treatment:
It is crucial to determine the underlying cause of the patient’s hypercoaguable state and treat it appropriately. 
Supportive:
1. Ensure patent airway, breathing present, circulation stable
2. NG decompression by nasogastric tube insertion and suction
3. Fluid resuscitation 
4. Bowel rest
5. Fluid input-output charting
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Pharmacological: 
• Lytic therapy: Thrombolysis using recombinant tissue plasminogen activator (rt-PA) administered 
according to local protocols. 
• Anticoagulation: Heparin administered initially until the desired APTT range was achieved. Once 
an APTT of 2.5-3 was achieved, the patient was  converted to warfarin. 
Surgical:
• Thrombectomy with thrombolysis
• Intravenous catheterisation with thrombolytic infusion
• Excision of infarcted non-viable bowel
Indications for surgery include:
• Peritonitis
• Bowel infarction
• Haemodynamic instability 
• Inadqeuate response to medical treatment
Prognosis:
This is highly dependent on the time taken to diagnose this condition and treat it appropriately. It is 
associated with 30% mortality rate and 25% recurrence rate in patients not given anticoagulant therapy. 
Anticoagulant therapy combined with surgery is associated with the lowest recurrence rate (3-5%). 
Superior mesenteric vein thrombosis is associated with the best prognosis from all aetiologies of 
mesenteric ischaemia. 
Final treatment and follow ups:
The patient’s parameters and progression of general condition were monitored. He was discharged from 
the intensive therapy unit two days after admission to hospital and was admitted to a surgical ward. 
His APTTr was monitored and the dose of heparin was increased or decreased by 500U accordingly. 
Once the target APTTr range (2.5-3) was achieved, the patient was started on warfarin. He was started on 
10mg warfarin for two days and on the second day his International Normalised Ratio (INR) was taken. 
On the third day since warfarin was started, his warfarin dose was reduced to 5mg (as per protocol). 
Heparin was stopped once his INR was more than 2. Antibiotics were also stopped.
Mr. G.B’s condition got progressively better. He opened his bowels, was started on light feeds and was 
mobilised. He was deemed fit for discharge ten days after admission, on 5mg warfarin. He was informed 
that he will need lifelong warfarin and was informed regarding the associated side-effects and interactions. 
He will be followed up at the ACCX clinic daily for two weeks and then accordingly. 
A repeat CT chest thorax and abdomen was performed in order to exclude any underlying pathology 
responsible for the thrombosis. The CT showed clear lungs with scattered bronchiectasiae, no lymph 
node enlargement, no organ pathology or free fluid. Thrombosis of the superior mesenteric vein was seen 
to have completely resolved. 
The patient will be followed up at surgical outpatients clinic in three months and was referred for a 
haematological consultation for coagulation studies. 
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Fact Box 9:
Title: Superior Mesenteric Vein Thrombosis 
Incidence: 10-15% of cases of mesenteric ischaemia.
Risk Factors: Hypercoaguable states, abdominal sepsis and inflammation, malignancy, trauma and post-
abdominal surgery. 
Presentation: Insidious onset, abdominal pain, abdominal distension and tenderness.
Diagnostic Investigation: CT scan, MRI 
Treatment: Resuscitation, 
                   Pharmacological – thrombolysis, anticoagulation
                   Surgical – thombectomy with infusion of thrombolysis, excision of non-viable bowel
Prognosis: High mortality attributed to long delay in diagnosis. If treated promptly and adequately, mor-
tality is significantly reduced and recurrence is reduced to 3-5%.
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